Author:
Matsumoto Naomi,Sasaki Ayako,Kadowaki Tomoka,Mitsuhashi Toshiharu,Takao Soshi,Yorifuji Takashi
Reference35 articles.
1. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting;Dagan;N Engl J Med,2021
2. BNT162b2 mRNA COVID-19 vaccine: first approval;Lamb;Drugs,2021
3. Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic;Horita;J Med Virol,2023
4. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020
5. WHO roadmap on uses of COVID-19 vaccines in the context of Omicron and high population immunity;World Health Organization,2023